Next Article in Journal
A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations
Next Article in Special Issue
Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC
Previous Article in Journal
Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer
Previous Article in Special Issue
Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations
 
 
Review

Article Versions Notes

Cancers 2022, 14(24), 6122; https://doi.org/10.3390/cancers14246122
Action Date Notes Link
article xml file uploaded 12 December 2022 13:30 CET Original file -
article xml uploaded. 12 December 2022 13:30 CET Update https://www.mdpi.com/2072-6694/14/24/6122/xml
article pdf uploaded. 12 December 2022 13:30 CET Version of Record https://www.mdpi.com/2072-6694/14/24/6122/pdf
article supplementary file uploaded. 12 December 2022 13:30 CET - https://www.mdpi.com/2072-6694/14/24/6122#supplementary
article html file updated 12 December 2022 13:31 CET Original file -
article html file updated 1 March 2023 03:50 CET Update -
article html file updated 4 March 2023 21:05 CET Update https://www.mdpi.com/2072-6694/14/24/6122/html
Back to TopTop